Maravai LifeSciences Holdings, Inc. (MRVI:NASDAQ) closed at $6.95 on October 19, 2026, up 2.36% on the day. The stock trades 26.2% below its 52-week high of $9.42 and 173.1% above its 52-week low of $2.55. Over the past year, it gained 105.8%. Maravai LifeSciences Holdings, Inc. is part of the Health Care sector.
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -3.82% | -6.60% | -2.86% | +88.09% | +105.76% |
In 252 trading sessions since October 16, 2025, MRVI closed higher on 120 days (48%). Its best day was August 19, 2026 (+25.78%) and its worst was January 28, 2026 (-10.00%). The stock moved 10% or more in a single session 5 times. It opened at least 5% above the previous day's high 3 times.
Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It generates a majority of its revenue from the Nucleic Acid Production that focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
Find more stocks like MRVI with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.